Scientists at ETH Zurich have broken new ground by generating over 400 types of nerve cells from stem cells in the lab, far ...

As startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress colorectal cancer stem-like cells, especially in early adenomas. Curcumin shifts ...

In partnership with Syneos Health, the Company has engaged eight clinical sites and counting, and patient enrollment and processing efforts are underway. The lead principal investigator for the trial ...

Our objective was to culture these cells in order to understand them and exploit their therapeutic potential to the full. Design Here, hypothesising that some CTC potentially have cancer stem cell ...

The CRC cell line was mixed and resuspended with culture medium and inoculated in 96-well plates at 5000/100ul, while 100 µL complete medium without cells was set up (as a control).

The -SG diet inhibited the growth of CRC cells in culture. The anti-proliferative effect was coupled with a delay in entering the synthetic phase of the cell cycle.

This antagonist effect between CBX3 and IFNγ on STAT1/PD-L1 expression was also observed in CRC. Strikingly, CBX3 deletion heightened CRC cells sensitivity to IFNγ, which ultimately enhanced their ...

Lipidomics Profiling Reveals Differential Alterations after FAS Inhibition in 3D Colon Cancer Cell Culture Models Brian D. Fries ...

CellResearch Corporation, a Singapore-based biopharmaceutical company today announced it has successfully closed the first Phase I study in CorLiCyte®, a stem cell therapy derived from umbilical cord ...

Methods: Senescence was induced in CRC cell lines by low-dose-etoposide treatment and confirmed by Senescence-associated β-galactosidase (SA-β-GAL) staining and fluorescence activated cell sorting ...